Corcept Therapeutics Faces Securities Fraud Lawsuit Over Misleading FDA Claims
Law firm Levi & Korsinsky filed class action suit against $CORT alleging fraud regarding relacorilant FDA approval prospects between October 2024 and December 2025.
CORTsecurities fraudclass action lawsuit